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ABSTRACT
Developmentally Regulated GTP-binding (DRG)
proteins are highly conserved GTPases that associ-
ate with DRG Family Regulatory Proteins (DFRP).
The resulting complexes have recently been shown
to participate in eukaryotic translation. The struc-
ture of the Rbg1 GTPase, a yeast DRG protein, in
complex with the C-terminal region of its DFRP
partner, Tma46, was solved by X-ray diffraction.
These data reveal that DRG proteins are
multimodular factors with three additional domains,
helix–turn–helix (HTH), S5D2L and TGS, packing
against the GTPase platform. Surprisingly, the
S5D2L domain is inserted in the middle of the
GTPase sequence. In contrast, the region of
Tma46 interacting with Rbg1 adopts an extended
conformation typical of intrinsically unstructured
proteins and contacts the GTPase and TGS
domains. Functional analyses demonstrate that the
various domains of Rbg1, as well as Tma46,
modulate the GTPase activity of Rbg1 and contrib-
ute to the function of these proteins in vivo. Dis-
secting the role of the different domains revealed
that the Rbg1 TGS domain is essential for the re-
cruitment of this factor in polysomes, supporting
further the implication of these conserved factors
in translation.
INTRODUCTION
GTPases form a large family of universally represented
proteins that have been involved in many cellular func-
tions. Phylogenetic analyses have demonstrated that
GTPases organize themselves in two distinct classes (1).
The best-known branch was named TRAFAC as it con-
tains GTPases involved in translation (TRAnslation FACt
ors). Besides translation factors, this branch also encom-
passes the well-known trimeric GTPases involved in signal
transduction, septins and the RAS subfamily of GTPases.
These proteins are characterized by the presence of a
GTP-binding domain (G-domain) that contains ﬁve char-
acteristic motifs, G1 [Walker A/P-loop, GxxxxGK(S/T)]
responsible for binding of a- and b-phosphate groups of
the nucleotide, G2 [Switch I, x(T/S)x] that binds Mg2+, G3
(Walker B/Switch II, DxxG) that interacts with the nu-
cleotide g-phosphate and Mg2+, G4 [(N/T)KxD] where K
and D bind directly to the nucleotide, and the weakly
conserved G5 involved in guanine base recognition.
Small G-proteins have been extensively characterized
and found to act as important molecular switches
through changes in conformation related to the presence
and nature of the bound nucleotide (none, GDP, GTP). In
particular, the conformational changes occurring as a
result of GTP hydrolysis has been shown to transduce
cellular signals to downstream effectors mainly through
changes in switch I (G2) and II (G3) regions (2). The
critical function of GTPases in several biological processes
is illustrated by the involvement of these proteins, and
factors stimulating their catalytic activity or mediating
nucleotide exchange, in many physiological disorders
including cancer.
The TRAFAC class of GTPases is subdivided into
several superfamilies (1). Among them, the classical trans-
lation factor subgroup contains the well-known family
of ubiquitous translation factors (EF-Tu/EF-1a,
EF-G/EF-2, initiation and termination factors) as well
as three less well-characterized protein families named
Bms1-like, HﬂX and OBG. Interestingly several of the
latter factors were linked to ribosomes either through a
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direct role in translation or through their implication in
ribosome biogenesis [e.g. (3,4–8)]. The Developmentally
Regulated GTP-binding proteins (DRGs) belong to the
OBG family of GTPases (which also contains the Obg/
CgtA, YyaF/YchF, Nog1 and Ygr210 sub-branches).
DRGs are strikingly conserved in archaea, fungi, plants
and animals. In addition to the GTPase domain, these
proteins also contain a C-terminal TGS domain of
unknown function. TGS domains are also found in
other GTPases of the OBG family and is shared with
threonyl-tRNA synthetases (ThrRSs) and guanosine poly-
phosphate phosphohydrolases/synthetases (SpoT/RelA)
[the acronym TGS being derived from ThrRS, GTPase
and SpoT (9)]. DRGs were ﬁrst characterized by their
abundant expression in mouse embryonic brain showing
subsequent downregulation in adult tissue (10,11). While
archaea contains a single drg gene, two distinct DRG
subtype, Drg1 and Drg2, are encoded by eukaryotic
genomes (12). Some plants harbor three distinct genes,
two of them code for nearly identical Drg2 subtype
proteins that are likely to result from a recent gene dupli-
cation event (13). Two-hybrid screens and coimmuno-
precipitation experiments revealed that DRG GTPases
interact with conserved partner proteins in yeast and
human. Those were named DRG Family Regulatory
Protein (DFRP). Dfrp1 (also known as Lerepo4 in
human) binds speciﬁcally to Drg1 while Dfrp2 preferen-
tially binds to Drg2 (14,15). Dfrp1 and Dfrp2 contain a
C-terminal region of 60 amino acids that was found to
be required for binding to DRG and is named the dfrp
domain (14). Else, Dfrp1 and Dfrp2 are highly divergent
proteins, the former containing at its N-terminus two zinc
ﬁngers potentially mediating interactions with RNA while
the latter contains a RWD domain that was identiﬁed in
proteins interacting with the translational regulator Gcn1
(16). DFRP factor presence is important for the mainten-
ance of normal levels of the cognate DRG proteins in
human cells. Moreover, DRG–DFRP complexes were
found to be localized in the cytoplasm of mammalian
cells where the Drg1–Dfrp1 heterodimer was speciﬁcally
found to associate with polysomes (17).
The yeast Drg1 homolog is named Ribosome-binding
GTPase 1 (Rbg1) as it was found associated to ribosome
(18,19). It associates with yeast Dfrp1, namely Tma46,
which is also a ribosome-associated protein (15,18).
Consequently, yeast Drg2 was named Rbg2 (Ribosome-
binding GTPase 2) even if, like its human counterpart, it
fails to cosediment with polysomes (15,17). Rbg2 associ-
ates with yeast Dfrp2, namely Gir2 (15). Consistent with
the presence of a RWD domain, Gir2 was found to bind
to Gcn1 (15,19). Yeast Rbg1 and Rbg2 are highly similar
between themselves and with their human counterparts,
Rbg1 sharing 66% identity and 80% similarity with
human Drg1 and Rbg2 59% identity and 80% similarity
with human Drg2. The sequence conservation of DFRP
factors between these two species is however much lower.
Although phylogenetic evidence and biochemical
fraction studies have linked the DRG proteins to transla-
tion, differentiation and growth, the exact molecular
function of these GTPases is as yet unknown. Early
studies have suggested that mouse and human Drg1
interacts in vitro and in vivo with the oncogenic T-cell
acute lymphoblastic leukemia (Tal1/Scl) protein, a basic
helix–loop–helix (bHLH) transcription factor involved in
cell growth and differentiation (20,21). It was also
reported that overexpression of Drg1 increased rat embry-
onic ﬁbroblast transformation induced by c-myc and ras
overexpression, affecting both the onset and average size
of foci formed (20). Drg2 was also reported to be
downregulated in SV-40 transformed ﬁbroblasts in com-
parison to normal ﬁbroblasts (22). In other studies, mam-
malian Drg1 was also found to be a target for
SUMOylation stimulated by the MEKK1 Map3 kinase
(23) or shown to interact with the protein kinase
MPSK1 (STK16) in a process requiring the N-terminal
65 residues of Drg1 (24). In yeast, ﬁlamentous invasion
into agar matrices by Candida albicans was attenuated by
a Drg1 null mutation, concomitantly causing delayed
lethality when the mutated organism was injected intra-
venously into mice. These phenotypes were suggested to
result from the association of C. albicansDrg1 with Efg1 a
bHLH transcription factor involved in repression of
invasiveness (25). Many of these observations are difﬁcult
to reconcile with the conserved association of Drg1 factors
to ribosomes. In yeast, deletion of RBG1, or RBG2, does
not impair cell growth. Moreover, only very weak growth
phenotypes resulting from double deletions of RBG1 and
RBG2 could be detected using a sensitive competitive
growth assay (26). An important step forward was made
by the observation that a triple-deletion mutant lacking
RBG1, RBG2 and the gene encoding the putative RNA
helicase Slh1 exhibited a strong negative growth pheno-
type (15). Importantly, translation is impaired in this triple
mutant, as evidenced by the presence of reduced levels of
polysomes. Similar phenotypes were observed for other
combinations of mutation inactivating simultaneously
the Rbg1–Tma46, Rbg2–Gir2 and Slh1 functions, suggest-
ing that these three entities mediate overlapping functions
in translation (15).
To gain further insights into the function of Rbg1 and
Tma46 and the mode of interaction of these two proteins,
we decided to investigate the structure of this heterodimer.
Only a few structures of GTPase of the OBG subfamily
are currently known. This includes Bacillus subtilis Obg
(PDB ID 1LNZ) and human OLA1 of the YyaF/YchF
subfamily (PDB ID 2OHF), the only structure available
so far for a DRG subfamily member being the NMR
solution structure of the C-terminal TGS of human
Drg1 (PDB ID 2EKI). Our crystal structure revealed the
presence of novel domains in Rbg1 and uncovered the
mode of interaction of Rbg1 with Tma46. Based on this
information, in vitro and in vivo assays allowed us to
dissect the role of the Rbg1–Tma46 domains and inter-
actions in GTPase function and polysome recruitment.
MATERIALS AND METHODS
Plasmids
Plasmids were constructed using standard cloning strategies
or by site-directed mutagenesis using the QuickChange
strategy (Stratagene, La Jolla, CA, USA) with minor
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modiﬁcations to manufacturer’s instructions. For expres-
sion constructs, an iterative trial and error process
starting from plasmids encoding His6-tagged complete
Rbg1 and full-length Tma46 was used. Protein yields,
subunit interaction and homogeneity were assessed by gel
electrophoresis after puriﬁcation on Ni–NTA. When neces-
sary, mass spectrometry analyses, apparent fragment sizes
and sequence comparisons were used in an attempt to
deﬁne suitable domain borders. For protein production,
expression plasmids were transformed into
BL21-CodonPlus (DE3)-RIPL. In some instances,
glycerol stocks of the transformed bacteria were stored at
80C until use. Material obtained from plasmids
encoding stable and well-expressed products were tested
for crystallization. Yeast plasmids were constructed as
described above and contained genes expressed under the
control of their native promoters. All constructs were
veriﬁed by sequencing.
All plasmids used in this study are listed in Supple-
mentary Table S1 while oligonucleotides used to prepare
these constructs are listed in Supplementary Table S2.
Puriﬁcation of recombinant proteins
Protein expression was induced by growth in autoinduc-
tion media [Formedium (27)] plus kanamycin and chlor-
amphenicol (50 mg/ml and 24 mg/ml, respectively) for 5 h at
37C followed by overnight growth at 20C. Cells
were harvested by centrifugation and pellets kept frozen
until further use. Rbg1ﬂ–Tma46205–345 selenomethionine-
substituted protein was obtained by using the autoinduc-
tion method (28,29). Small-scale protein production
(100–200ml) and puriﬁcation were essentially performed
as described earlier (30) except that BL21 CodonPlus was
used for protein expression and buffer B (50mM Tris–
HCl pH 7.4, 20mM imidazole, 300mM NaCl, 2mM
ß-mercaptoethanol, 10% glycerol and 0.2% Igepal) for
afﬁnity puriﬁcation on Ni–NTA. Proteins were eluted in
buffer B containing 500mM imidazole. For large-scale
preparations, pellets were thawed on ice and mixed with
lysis buffer [300mM NaCl, 20mM imidazole, 2mM
b-mercaptoethanol (b-MeOH), 50mM Tris pH 8.0,
0.2% NP40 and a protease inhibitor cocktail tablet
(Complete, EDTA-free, Roche)] and sonicated. After cen-
trifugation at 30 600g at 4C for 30min, the lysate was
ﬁltered through a 0.45 mm sterile ﬁlter before loading
onto a 5ml HisTrap FF Chelating column pre-loaded
with 100mM NiSO4 and equilibrated in Buffer A
[300mM NaCl, 20mM imidazole, 2mM
b-mercaptoethanol (b-MeOH), 50mM Tris pH 8.0].
After washing the column with 10 bed volumes of Buffer
A, proteins were eluted with a gradient of imidazole
(20–500mM) using an A¨KTA Puriﬁer (GE Healthcare).
Protein containing fractions were pooled and concen-
trated at 4C to a ﬁnal volume of 1–2ml using Amicon
Ultra centrifugal ﬁlter devices. The concentrate was
directly loaded onto a pre-equilibrated size exclusion
column [Sephadex 200 or 75 (16/60 or 26/60) columns]
at 4C and the protein eluted in buffer S (150mM NaCl,
20mM Tris pH 7.5 and 2mM DTT) at rates
of 1.0ml/min using an A¨KTA Prime system. Puriﬁed
proteins were then pooled and concentrated to
20–60mg/ml by ultraﬁltration at 4C using the Amicon
concentrator before ﬂash-freezing in liquid nitrogen and
storing at 80C. The puriﬁcation protocol for the seleno-
methionine-substituted proteins was as above except that
in the last step of the puriﬁcation 5mM concentration of
DTT was included to prevent selenomethionine oxidation.
Crystallization, data collection, structure reﬁnement
and analysis
Crystals of Rbg1ﬂ–Tma46205–345 complex were obtained
by the vapor diffusion method. The drops were setup at
4C with 1 ml of 60mg/ml of protein and 1 ml of reservoir
solution (2.38M sodium formate, 0.2–0.5M sodium
citrate pH 6.5). Three dimensional rectangular crystals
with typical dimensions 0.3 0.05 0.02mm grew in
about 2 weeks. The X-ray diffraction data for the native
and selenomethionine derivative were collected from
single crystals at the beam line ID14-4 (31) at the
European Synchrotron Radiation Facility at Grenoble,
France using an ADSC Quantum Q315r CCD detector.
The data were indexed and integrated using MOSFLM
(iMOSFLM) and scaled with SCALA in the CCP4 suite
(32). Heavy atom site search and phasing were done using
SHARP (33) and model building/tracing were done using
ARP/wARP (34). Cycles of manual model building were
performed with the program Coot (35). Waters were
introduced into the model using ARP/wARP program
and validated with the electron density maps in Coot.
The structures were reﬁned with REFMAC (36) for iso-
tropic reﬁnement. TLS groups were deﬁned and used for
anisotropic reﬁnement. This included 17 groups com-
prising of Rbg1 (chain A 2–45, 53–125/131–174/233–299,
175–232, 300–369; chain B 2–53, 54–91/98–125/133–174/
233–299, 175–232, 300–369) and Tma46 (chain C 214–240,
241–267, 268–282, 302–313, 314–338; chain D 214–240,
241–267, 268–282, 320–336). Superimpositions between
the structures were done using the SSM superpose
function in Coot and analysis of the electrostatic surface
potential was performed using APBS (37) in Pymol, also
used for generating the structure ﬁgures (38).
GTP binding and hydrolysis assay
Thermal shift assays were performed using protein
samples at 0.05mM in buffer S with 5 Sypro Orange
(Sigma), with or without 0.2mM GDP, GTP or 0.5mM
GTPgS in wells of MicroAmp 96-well Fast Optical
Reaction plate (Applied Biosystems). Fluorescence was
measured from 20C to 85C in increments of 1C in a
T7500 Fast Real-Time PCR system (Applied Biosystems).
Results were analyzed using the GraphPad Prism 4
software (GraphPad Software Inc.).
GTP hydrolysis assays using Malachite green (39) were
performed as follows: solutions (5.72% w/v ammonium
molybdate in 6N HCl, 0.08% w/v malachite green
solution, 2.32% w/v polyvinyl alcohol) were prepared in-
dividually using reagents from Sigma Aldrich and stored
at 4C. For assays, MilliQ water: Malachite green: poly-
vinyl alcohol: ammonium molybdate were mixed in a ratio
of 2:2:1:1 and incubated for 3 h until they became yellow.
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Fifty microliters of protein samples (20mM) in ﬁltered and
degassed buffer (100mM KCl, 50mM Tris pH 7.5 and
5mM MgCl2) were incubated with GTP (Sigma Aldrich)
for 1 h at 37C in Microtest 96-well ﬂat bottom plates
(Sarstedt). An amount of 200 ml of Malachite green
reagent was added in all wells and the absorbance readings
at 630 nm were measured immediately in a Wallac Victor2
1420 Multilabel Counter. A phosphate standard prepared
from KH2PO4 and blank with no protein were included on
the plate. The latter background was subtracted from the
protein sample readings. Data were ﬁtted to Michaelis–
Menten equation using non-linear regression in
GraphPad Prism 4 to determine the kinetics.
Yeast strains and growth assays
Yeast strains are all derived from BMA64 (40) and are
listed in Supplementary Table S3. Strains containing a
single disrupted and epitope-tagged gene were obtained
by transformation with TAP-tag (41) and HISMX6 (42)
modules carrying short ﬂanking sequences homologous to
the targeted gene. Primer sets that were used for that
purpose are described in Supplementary Table S2.
Transformants were checked for correct integration by
PCRs. Plasmids were introduced into yeast strain using
the standard LiOAc transformation method (43).
For growth assays, yeast cultures were grown to satur-
ation in selective liquid media. The cultures were then
diluted in water to an optical density at 600 nm (OD600)
of 0.1. Three microliters of these cultures and 10-fold
serial dilutions were spotted onto agar plates containing
complete synthetic media minus leucine. Plates were
incubated at 37C and 30C for 3 or 4 days, and cell
growth was determined by visual inspection and docu-
mented by photography.
Western blot analyses
Proteins from immunoprecipitation experiments, or total
yeast extract (44), were fractionated by sodium dodecyl
sulphate–polyacrylamide gel electrophoresis (SDS–
PAGE) and subsequently transferred to nitrocellulose
membrane. TAP-tagged proteins were detected as
described earlier (45). HA-tagged proteins were detected
using mouse anti-HA monoclonal antibody (Covance
MMS-101P) and a secondary goat-anti-mouse IgG
antibody (Jackson 115-035-068). As loading control
Stm1 was detected by a polyclonal anti-Stm1 antibody
and a secondary goat-anti-rabbit IgG antibody (Pierce
31460). Chemiluminescence was recorded with a
LAS4000 device (GE Healthcare).
Immunoprecipitation of epitope-tagged proteins
Logarithmically growing yeast cells in selective medium at
30C were resuspended in lysis buffer containing 10mM
Tris–HCl pH 7.5, 150mM NaCl, 5mM MgCl2, 1mM
DTT and protease inhibitors. Cells were broken by
mixing with glass beads. The cell extract was obtained
by two consecutive centrifugations, the ﬁrst 20min at
14 000g and the second 10min at 14 000g. Glycerol was
added to a ﬁnal concentration of 10%. An amount of
30mg/ml of total proteins were incubated with IgG
Sepharose Beads (GE Healthcare) or IgG coupled to
Dynabeads on a rotor at 4C for 2 h. Beads were
pelleted and washed extensively with IPP150 buffer
(10mM Tris–HCl pH 7.5, 150mM NaCl, 5mM MgCl2).
Proteins bound to the beads were eluted with SDS–PAGE
sample buffer by boiling for 5min.
Polysome analyses
Polysomes were analyzed essentially as described previ-
ously (15).
RESULTS
Structure determination of the yeast
Rbg1ﬂ–Tma46205–345 complex
To obtain recombinant Rbg1 and Tma46, or truncated de-
rivatives thereof, for structural and functional analyses, we
constructed artiﬁcial operons encoding various versions of
6His-tagged Rbg1 followed by Tma46. Initially, full-length
Rbg1 and Tma46 were used. The two proteins copuriﬁed
indicating that no yeast-speciﬁc factor or compound was
necessary to allow their interaction. However, low complex
yields and truncated forms of Tma46 were observed. Mass
spectrometry analyses and estimation of apparent molecu-
lar weights, together with sequence analyses delineating
borders of conserved domains, provided rough estimates
of the missing regions. After several iterative cycles of con-
struct optimization, a plasmid expressing efﬁciently and
without apparent degradation 6His-tagged full-length (ﬂ)
Rbg1 together with the C-terminal region of Tma46 (amino
acids 205–345) encompassing the DFRP region was
obtained.
The X-ray crystal structure of proteins obtained with
the latter construct was solved to 2.67 A˚ resolution by
the SIRAS method using a selenomethionine-substituted
protein. The ﬁnal model of the Rbg1ﬂ–Tma46205–345
complex (R-factor 19.7%, Rfree 22.2%) includes two mol-
ecules of the complex in the asymmetric unit although the
complex behaves as a heterodimer by size-exclusion chro-
matography. The asymmetric unit contains Rbg1 mol-
ecules A and B interacting with Tma46 molecules C and
D, respectively; molecule AC is used hereafter for the
structural description. The data collection and reﬁnement
statistics are as given in Table 1. Rbg1 was modeled from
2 to 369 in both molecules A and B, but some of the loops,
in particular those comprising the G-motifs, had poor
electron density due to their ﬂexibility. Seventy-seven
water molecules in the ﬁrst solvation shell were included.
The Rbg1 structure shows a domain organization that
includes the well-conserved G-domain (G1+G2+G3=
64–169; G4+G5=245–293), an N-terminal helix–turn–
helix (HTH) domain (1–44) which lies adjacent to
another domain formed by a 65-residue long insertion
(176–240) between G3 and G4 of the G-domain and the
TGS domain at the C-terminus (294–369) (Figure 1).
The G-domain of Rbg1 is highly similar to the
well-conserved GTP-binding domain of other GTPases,
in particular proteins Obg, YchF, FeoB, HﬂX, Ras-
related proteins or Era, which all belong to the
TRAFAC class of GTPases. The G-domain contains ﬁve
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a-helices (a3, a4, a5, a8 and a9) and six b-strands (b1, b2,
b3, b4, b10 and b11). The G1 motif (P-loop/Walker A) is
located on the loop connecting b1 to a3, G2 (Switch I) in
between a3 and b2, G3 (Switch II/Walker B) at the end of
b3 strand, G4 in b10 and G5 motif in b11 (Figure 1).
While the G-domain of chain A and chain B adopt the
same overall fold [root mean square deviation (RMSD)
over the backbone Ca atoms is 0.96 A˚], differences were
observed especially in the loops containing the ﬁve
G-motifs. Superimposing human OLA1 structure bound
to ATP onto the G-domain of the two chains indicated
that the P-loop in chain A adopted a closed conformation
where entry of GTP could be difﬁcult whereas chain B had
an open conformation. The loops containing the G2 and
G3 motifs were also shifted although the electron density
in this area was not complete. We cannot however rule out
that the observed conformational difference in this area
might be due to crystal packing contacts.
Previous reports have shown that DRG factors contain
about 65 amino acids inserted between the G3 and G4
motifs of the G-domain that are not found in other Obg
family members and had no sequence homology to known
domains (19). This region (residues 176–240) folds as an
independent domain emerging from the G domain. We
named this new domain of Rbg1 the S5D2L domain as
database searches indicate that its topology is related to
the ‘Ribosomal protein S5 domain 2-like’ (S5D2L) super-
family despite the absence of signiﬁcant sequence similar-
ity. The latter superfamily has 13 members (as according to
Pfam, CATH and SCOP) and structural alignment shows
that whereas the other members have a bbbaba fold,
S5D2L domain has bbaba fold lacking the ﬁrst b strand
(Supplementary Figure S1). The bacterial 30S ribosomal
S5 subunit protein C-terminal domain is structurally the
most similar to S5D2L domain, aligning with an RMSD of
2.2 A˚ over 51 residues although the sequence identity was
very low (12%). Interestingly, the residues Gly and Arg of
the S5 subunit protein known to cause ribosomal ambigu-
ity when mutated (46) are fully conserved in Rbg1 (Gly189
and Arg207). Equivalent residues are also present in EF-G
domain IV. The nature of these residues is however not
universally conserved, as they are not found in GHMP
kinase family members. A short parallel b sheet formed
by b5 and b9 tether the S5D2L structure on the back of
the G domain between the segments containing the G3 and
G4 motifs.
The two amphipathic helices, a1 and a2 (2–44), com-
prises a previously unnoticed HTH domain at the
N-terminal of Rbg1. While the HTH and S5D2L struc-
tures form a single globular protuberance emanating from
the G domain, we refer to them as independent domains,
as sequence phylogeny and functional data (see below)
indicate that they behave as separate entities. The HTH
is stabilized mainly by a hydrophobic zipper between the
two helices, ﬁve leucines positioned 3–4 residues apart in
the longer helix a2 contributing to the zipper while the
other side of the helix a2 makes both hydrophilic and
hydrophobic interactions with the S5D2L helices a6 and
a7. Additionally, the interface between a1 and a2 is also
stabilized by hydrogen bonds between Glu12 (a1)–Arg39
(a2) and Glu14 (a1) and His27 (a2).
The C-terminal TGS domain (294–369) has predomin-
antly b sheet structure with ﬁve b strands (b12–b16) and
two helices, a10 and a11 (Figure 1). Superimposition of
the Rbg1 TGS domain with the previously reported NMR
solution structure of human Drg1 TGS domain (PDB ID
2EKI) gave an RMSD of 1.31 A˚ over 76 Ca atoms. The
TGS domain was found to be structurally very similar to
threonyl tRNA synthetase, YchF and hOLA1 TGS
domains and ubiquitin.
The HTH, S5D2L and TGS domains lie on the distal
part of the GTP-binding pocket (Figures 1 and 2).
Electrostatic surface potential analysis shows an extensive
positively charged surface formed partly by the TGS,
Table 1. Data collection and reﬁnement statistics of the Rbg1ﬂ–
Tma46205–345 complex structure
Data collection
Space group P21212
Unit cell parameters
a, b, c (A˚) 86.2, 224.89, 84.89
a, b,  () 90.0, 90.0, 90.0
SeMet (peak) Native
Wavelength (A˚) 0.9795 1.0332
Completeness (%) 99.6 (99.6) 99.9 (99.9)
Mean I/s(I)a 21.6 (5.9) 15.6 (4.4)
Rmeas (%)
b 8.3 (42.3) 8.1 (43.4)
Reﬁnement
Resolution (A˚) 56.22–2.67 (2.74–2.67)
No. of reﬂections 46457
Reﬂections
used in Rfree
1200
Rfactor
c 19.7%
Rfree
d 22.2%
Stereochemistry
Res. in favored
regions (%)
89.7
Res. in allowed
regions (%)
10.2
Number of atoms
Protein 7030
Water 77
Mean B-factor-Overall 76.935
RMSDe
Bond lengths (A˚) 0.007
Bond angles () 1.233
Residues modeled
Rbg1 A 2–45, 53–125, 131–369
Rbg1 B 2–91, 98–125, 133–369
Tma46 C 214–282, 302–338
Tma46 D 214–282, 320–336
Residues with missing
side chain
Rbg1 A Lys329
Rbg1 B Ala46, Ser47, Ser48,
Ser50, Lys369
Tma46 C Glu307
Tma46 D Leu214, Glu215, Asp320
Numbers in parenthesis indicate the highest resolution shell statistics.
aMean [I/(I)] is the average of the relation between the intensity of the
diffraction and the background.
bRmeas={hkl [N/(N 1)]1/2 i jIi(hkl)<I(hkl)>j}/hkl i Ii(hkl),
where Ii(hkl) are the observed intensities, <I(hkl)> are the average
intensities and N is the multiplicity of reﬂection hkl.
cRfactor=hkl {[Fobs(hkl)] [Fcalc(hkl)]}/hkl [Fobs(hkl)], where Fobs(hkl)
and Fcalc(hkl) are the structure factors observed and calculated,
respectively.
dRfree corresponds to Rfactor calculated using 2.5% of the total reﬂec-
tions selected randomly and excluded during reﬁnement.
eRMSD is the root mean square deviation.
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HTH, S5D2L and part of the G-domain opposite to the
GTP-binding site (Figure 2).
Tma46 structure and interaction with Rbg1
Tma46 fragment present in the structure shows a non-
globular type of fold predominantly formed by a helices
interconnected by coils. The residues of Tma46205–345 in the
complex with Rbg1 that we could model into the electron
density are located as mainly four helices (numbered in this
study as a1–a4; note however that 19 residues between a3
and a4 were not modeled) and a short b strand which forms
b sheet structure with adjacent b strands b2, b3, b1, b4, b10
and b11 from the G-domain of Rbg1. Tma46 helices
Figure 1. Structure of the Rbg1ﬂ–Tma46205–345 complex with sequence information. (A) A surface representation of the Tma46 C-terminal fragment
(pink) enveloping Rbg1 (pale blue) is shown on the left. The individual components are shown color-coded on the right: the Tma46 C-terminal
fragment (pink) and Rbg1 with the G-domain (pale blue, this includes the short b sheet formed by b5 and b9 connecting the S5D2L domain), the
protuberance formed by the HTH and S5D2L domains (purple) and the TGS domain (blue). The GTP-binding pocket is also represented with the
ﬁve G motifs colored as orange. A schematic domain organization of the structurally solved complex is also shown. (B) The component sequences
and secondary structure elements of the crystallized complex are represented with the G-motifs (G1–G5) given in bold letters. Domain boundaries are
indicated in the same color scheme as in Figure 1A.
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envelops Rbg1 forming an extended and extensive interface
(buried surface area in the interface 2978 A˚2) contacting
the G-domain (helices a1, a2 and ß strand) and the TGS
domain (helices a3 and a4) with no contacts with the
S5D2L and HTH domains (Figures 1 and 2). Based on
weak sequence similarities between Dfrp1 and Dfrp2, it
was earlier proposed that the region corresponding to
residues 280–332 of Tma46 constituted a DFRP domain
responsible for interaction with Rbg1 (14). Based on
two-hybrid screen results, it was also previously suggested
that Tma46 residues 254–296 would constitute the Rbg1-
binding site (19). Our complex structure demonstrates that
the region of Tma46 contacting Rbg1 is larger than these
earlier estimates and encompasses residues 216–279 and
302–338. This observation suggests further that the
DFRP region deﬁned earlier is only a fraction of the bio-
logically relevant unit involved in DFRP–DRG protein
interaction and that the region of Gir2/Dfrp2 involved in
contacting Rbg2/Drg2 is also larger.
One of the most prominent interacting surfaces between
Rbg1 and Tma46 comprises a8 helix of Rbg1 (between G4
and G5 motifs), which inserts between helices a1 and a2 of
Tma46 themselves interacting in turn also with Rbg1 a5
and a9 respectively. Helix a2 is longest in the fragment of
Tma46 solved, and extends from the Rbg1 G-domain to
the TGS domain that it contacts with its C-terminal end.
Interestingly, the interface between Tma46 a2 and Rbg1
a8/a9 consists mainly of aromatic ring containing residues,
which form a p-stacking interaction. Speciﬁcally, Tyr264
(a8) and Trp278 (a9) of Rbg1 form stacking interactions
with Phe246, Trp249 and His253 of a2 of Tma46
(Supplementary Figure S2).
Dissecting Tma46 interaction with Rbg1
These structural data allowed us to analyze in detail how
Tma46 recognize Rbg1. As this involves a fragment of
Tma46 that does not fold as a globular domain, but
rather as a string of independent structural elements that
meander on the surface of Rbg1, it is likely that Tma46 is
intrinsically unfolded and only adopt the observed con-
formation upon binding to Rbg1. Interestingly, this is
likely to also apply to Gir2 which was shown to be intrin-
sically unstructured (47).
We constructed stepwise deletion of aHA-tagged version
of the TMA46 gene inserted in a yeast centromeric vector,
removing deﬁned structural elements that interact with
Rbg1. Four mutants removing successively the Tma46 ß
strand, helix a4, helix a3, helix a2 from the C-terminus
and two mutants removing successively helix a1 and helix
a2 from the N-terminus were built. Finally, we also con-
structed a mutant replacing helix a2 (residues 243–268)
with an alanine linker of sufﬁcient length to bridge helices
a1 and a3.We ﬁrst tested whether these mutants were func-
tional by assaying their ability to complement the triple
mutant Dgir2Dtma46Dslh1 for its slow growth phenotype,
a feature exacerbated at 37C (15). We controlled by
western blotting that the mutant proteins were expressed
Figure 2. Electrostatic surface representation. The solvent-accessible surface electrostatic potential of the Rbg1ﬂ–Tma46205–345 complex as calculated
by APBS (Pymol) is shown as a surface alongside the cartoon representation. The potential is given with the negative (red) and positive (blue)
contour levels in the range from 8.0 to+8.0 kBT respectively. The left ﬁgure shows the positively-charged surface formed partly by the G, HTH,
S5D2L and TGS domains.
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and accumulated to normal levels (Figure 3B). A control
plasmid encoding a complete Tma46 restored a wild-type
phenotype demonstrating that the presence of the tag does
not impact on its function. Deletion of the Tma46 ß strand,
alone or in combination with helix a4 does not impair
Tma46 function. Removing the ß strand with helices a4
and a3 partially disrupts Tma46 activity while removing
the region extending from the C-terminus and including
helix a2 inactivate Tma46 (Figure 3A). Tma46 mutant
levels were normal (Figure 3B) demonstrating that the
partial activity did not result from protein instability but
rather from inactivity. Reciprocally, deletion of helix a1,
or replacement of helix a2 with an alanine linker, had
limited effects on Tma46 level or function whereas
deletion of helices a1 and a2 destabilized the protein
resulting concomitantly in a poor complementation
(Figure 3A and B).
We next assessed whether these mutations of Tma46
affect interaction with Rbg1 in vivo. For this purpose,
plasmids encoding the mutant were introduced in a
Dtma46 strain carrying a TAP-tagged Rbg1 allele.
Extracts prepared from transformants were incubated
with IgG beads to precipitate TAP-tagged Rbg1 and
associated factors. Presence of Tma46, and as a control
of Rbg1-TAP, in the input and immunoprecipitated frac-
tions (pellets) was assessed by western blotting (Figure 3C
and D). This analysis demonstrated that deletions of the
Tma46 ß strand or of the ß strand with helix a4, do not
affect interaction with Rbg1. Only a low level of Tma46
lacking helix a1 was coprecipitated with Rbg1. In contrast,
Tma46 proteins lacking larger fractions of the interaction
region (deletion of ß strand with helices a4 and a3 or of
ß strand with helices a4–2, substitution of helix a2 with a
linker or removal of helices a1 and a2) do not coprecipitate
with Rbg1 indicating that these mutations reduced afﬁnity
of Tma46 for Rbg1 or prevented interaction. Interestingly,
overexpression of the latter mutants using high copy
plasmids restored a speciﬁc interaction (Supplementary
Figure 3. Analysis of Tma46 mutants. (A) Complementation assay for Tma46 function. The ability of plasmid-encoded Tma46 mutants to
complement the growth phenotype of a triple Dtma46Dgir2Dslh1 strain was assayed by spotting serial dilution on selective plates and incubating
at 30C or 37C for 3 days. The structure of the various mutants is shown schematically on the left. Dark grey boxes indicate the Tma46 Zn-ﬁngers,
while the pseudo-cylinder represents the C-terminal region interacting with Rbg1. The hatched box indicates the alanine linker. WT strain indicates
the original wild-type parental strain without mutation. (B) Mutant protein accumulation. The level of accumulation of the mutant proteins in cells
shown on panel A grown at 30C was assessed by detecting the HA tag by western blotting. Uniform loading is supported by analysis of the levels of
the endogenous Stm1 protein. (C) Effect of C-terminal Tma46 truncation on its binding to Rbg1 in yeast. Extracts prepared from Dtma46 strains
carrying TAP-tagged Rbg1 and the various HA-Tma46 mutants grown at 30C were used for immunoprecipitation on IgG beads. As control for the
speciﬁcity of the coprecipitation a wild-type strain expressing wild-type Tma46 tagged with HA was used. Proteins present in extracts (Input) and
(co)precipitated factors (Eluate) were analyzed by western blotting. (D) Effect of deletion of helices a1 and a1+a2 of Tma46 on binding to Rbg1.
Samples were prepared as in panel C.
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Figure S3) to a detectable level, indicating that all mutants
are able to interact with Rbg1, albeit with much reduced
afﬁnity. Overexpressed a3–ß now complemented efﬁ-
ciently the TMA46 deletion while the a2 construct com-
plemented well independently of the vector used
(Supplementary Figure S3). In contrast, the a2–ß and
a1–a2 mutants were unable to rescue the Tma46
function even when overexpressed (allowing their accumu-
lation at a level higher than Tma46 in the wild-type strain).
Overall, these data suggest that interaction of Tma46 with
Rbg1 is important to provide activity, even though we
cannot formerly exclude Rbg-independent function of
Tma46. More importantly, these data demonstrate that
interaction of Rbg1 with Tma46 is not sufﬁcient to
provide activity. These results demonstrate further that
none of the Tma46 elements (helices a1–a4 and ß strand)
is absolutely essential for interaction and function. The
presence of superﬂuous elements, demonstrated by the
lack of functional phenotype and effect on interaction of
several mutants, may ensure an extremely tight binding.
Elimination of individual elements had different impact
either as a result of different effect on afﬁnity or because
they contribute to additional function(s) beside interaction.
The simultaneous removal of several elements always had
stronger effect than removing individually these elements
supporting the idea that they contribute in an additive
manner to Rbg1 binding. Interestingly, increasing protein
expression of interaction defective mutant was sufﬁcient to
restore Rbg1 binding suggesting that complex formation is
controlled by the concentration of the two partners.
However, even in such context, the larger deletions
(a2–ß or a1–a2) were unable to complement a Tma46
deletion. This indicates that Tma46 is not simply sticking to
Rbg1 but participates actively in the complex function,
possibly by strengthening the contacts between the G and
TGS domains of Rbg1 and/or by directly impacting on
Rbg1 GTPase activity.
GTP binding and hydrolytic activity of Rbg1 is modulated
by interaction with Tma46
DRG proteins have been shown to bind GTP and GDP
(11,48). Moreover, Arabidopsis DRGs have been reported
to hydrolyze GTP into GDP in vitro without the help of
GAPs or GEFs, unlike Ras-like proteins (13). To investi-
gate the effect of complex formation on GTP binding by
Rbg1, we performed thermal-shift assay in the presence or
absence of GTP, GDP or GTPgS for Rbg1 and Rbg1 with
the C-terminal part of Tma46 (Figure 4A). Nucleotide
binding of the complex was evidenced by an increased
melting temperature in the presence of the GDP, GTP or
non-hydrolysable GTPgS. Moreover, comparison of free
Rbg1 and the Rbg1ﬂ–Tma46205–345 complex revealed that
the increased stability detected in the presence of GTPgS
was speciﬁc for the complex, suggesting that complex for-
mation favors nucleotide binding. As negative control,
Rbg1ﬂ–Tma46205–345 containing three mutations in the
G1 motif (GFPSVGKS to GFPSVAMN) was used. No
increase in the unfolding temperature of this mutant
protein was seen in the presence of nucleotide. Since this
mutation was designed to abrogate nucleotide binding, this
observation conﬁrms that the shift in Tm observed for the
wild-type Rbg1ﬂ–Tma46205–345 complex is indeed due to
the protein–nucleotide complex formation.
We next analyzed the GTP hydrolytic activity of free-,
and Tma46-bound-, Rbg1. The Rbg1ﬂ–Tma46205–345
complex shows a weak GTP hydrolysis activity
(Figure 4B and Table 2), with parameters similar to those
reported for other Obg family of proteins (49,50) and
atDrg1/atDrg2a (13). A catalytic site mutant S79N (G1
motif changed from GFPSVGKS to GFPSVGKN, which
was shown to be inactive in vivo (15) did not show signiﬁ-
cant hydrolytic activity above the detection limit of the
assay (Figure 4B) conﬁrming the speciﬁcity of the
reaction. Additionally, the recombinant human homolog,
Drg1ﬂ–Lerepo4220–396 complex was about twice as active as
the cognate yeast complex (Table 2). For comparison,
Rbg1 and Drg1 showed signiﬁcantly reduced GTPase
activity on their own (Figure 4). The increased activity of
the complex over free Rbg1/Drg1 could be attributed
mostly to the fact that Rbg1 might be more stably folded
in presence of Tma46. This is evidenced, for example, by
the decrease in activity of Rbg1 in complex with a Tma46
mutant lacking the helix a1 (Table 2). Furthermore,
mutants of residues of Tma46 in the interface between
Rbg1 (helix a8 and a9) and Tma46 (helix a2 and nearby
residues) such as Ile241, Phe246, Trp249 and Lys250, the
latter two of which are involved in p-stacking, also show
reduced activity. Mutants of Tma46 at these positions dis-
played slightly reduced complementation of the TMA46
deletion (Supplementary Figure S4). Consistent with the
analysis of the a2 deletion, these mutants interacted
with Rbg1 as well as wild-type Tma46 (Supplementary
Figure S4). Thus, we conclude that speciﬁc contacts
between Tma46 and Rbg1 are important to stimulate the
GTPase activity of the latter in vitro and impact on Rbg1–
Tma46 function in vivo.
Role(s) of the different Rbg1 domains
The structure of the Rbg1–Tma46 heterodimer indicates
that Rbg1 comprises four domains. The GTPase domain
is the largest of them forming a platform surrounded by
protuberances corresponding to the HTH, S5D2L and
TGS domains. Previous analyses indicated that the
GTPase and TGS domains of Rbg1 were essential for its
function (15). However, careful examination of the struc-
tural data now available indicates that the TGS deletion
used extended into the GTPase domain. This situation was
probably responsible for the instability of the mutant
protein (15). The HTH and S5D2L had not been tested,
as sequence analyses had not identiﬁed them unambigu-
ously. We therefore constructed precise deletions of the
HTH, S5D2L or TGS domains in a functional HA-
tagged version of the RBG1 gene inserted in a yeast
vector. As deletion of the S5D2L removes an internal
part of the protein, two mutants were built incorporating
one or two glycine residues at the deletion point to allow
sufﬁcient ﬂexibility and length of the polypeptide
backbone to allow folding.
These mutants were ﬁrst assayed for their function
through their ability to complement the slow and
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temperature sensitive growth of a Drbg1Drbg2Dslh1 strain
(Figure 5A). Deletion of the HTH and TGS domain
inactivated Rbg1. Interestingly, removal of the S5D2L
complemented efﬁciently the mutant strain at 30C but
was unable to do so at 37C (Figure 5A) even though the
protein was stably expressed at both temperature (data not
shown). This result demonstrates that deletion of the
S5D2L domain did not disrupt the protein but that the
presence of the S5D2L domain is essential for the full
activity of Rbg1. Western blot analysis conﬁrmed that all
protein were expressed at (or near) wild-type levels
indicating that the HTH, S5D2L or TGS domains are
required for Rbg1 activity rather than stability (Figure 5B).
We next analyzed the roles of the different Rbg1
domains in mediating interaction with Tma46. Plasmids
encoding full-length or truncated versions of Rbg1
together with regions encompassing the C-terminus of
Tma46 (residues 154–345 or 205–345) were constructed.
Figure 4. GTP binding and hydrolysis. (A) Presence of 0.2mM GTP, GTPgS or GDP (in 4-fold excess over the protein concentration) causes an
increase in melting temperature of the Rbg1ﬂ–Tma46205–345 complex in the thermal-shift assay indicative of nucleotide binding. In contrast, addition
of a 10-fold excess of GTPgS (0.5mM) does not increase the melting temperature of Rbg1 alone. Also shown is the lack of increase in protein
unfolding temperature for a Rbg1ﬂ–Tma46205–345 G1 motif mutant (GFPSVAMN) in presence of 10 GTPgS. Note also that Rbg1ﬂ melts at a
much lower temperature than Rbg1ﬂ–Tma46205–345. (B) The GTP hydrolytic activity of Rbg1/Drg1, alone and in complex with
Tma46205–345/Lerepo4220–396, respectively, is represented as a graph with increasing substrate concentration in the x axis. A catalytic mutant
Rbg1ﬂ VFPSVGKN in complex with Tma46205–345 was used as a negative control.
Table 2. Kinetic parameters for GTP hydrolysis of the Rbg1–Tma46 complex and the mutant proteins
Vmax (nmol min
1mg1) Km (mM) kcat (min
1)
Rbg1ﬂ–Tma46205–345 0.0593±0.0018 304.1±32.5 0.0034
Drg1ﬂ+Lerepo4220–426 0.1154±0.0037 319.5±35.0 0.0074
Rbg11–294–Tma46205–345 (TGS) 0.0166±0.0022 426.3±165 0.0008
Rbg1175–243+Gly–Tma46205–345 (S5D2L) 0.0157±0.0028 221.5±159.2 0.0006
Rbg1ﬂ–Tma46239–345 (Tma46a1) 0.0370±0.0012 191.2±26.6 0.0020
Rbg1ﬂ–Tma46205–345 I241A, F246A 0.0288±0.0021 428.9±94.7 0.0017
Rbg1ﬂ–Tma46205–345 I241A 0.0406±0.0018 186.0±34.5 0.0023
Rbg1ﬂ–Tma46205–345 W249A K250E 0.0345±0.0014 425.8±52.6 0.0020
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After expression in Escherichia coli, the recombinant
proteins were puriﬁed on Ni–NTA thanks to the
presence of a 6His tag inserted at the N-terminus of the
Rbg1 fragment and protein eluates were analyzed by
denaturing gel electrophoresis and Coomassie staining
(Figure 5C). This analysis demonstrated that an inactive
GTPase (G1 motif GFPSVGKN, S79N) or a form of
Rbg1 lacking the S5D2L still interacted with Tma46. In
contrast, deletion of the TGS prevented Tma46–Rbg1
interaction (even though low residual binding was
occasionally detected). Interestingly, the TGS domain by
itself was sufﬁcient to interact with Tma46. Unfortunately,
the effect of deleting the HTH domain could not be ad-
dressed in this assay because the corresponding protein
was poorly expressed in E. coli.
To analyze the implication of the different Rbg1
domains in interaction with Tma46 in vivo, we introduced
the shuttle plasmids encoding HA-tagged truncated
versions of Rbg1 in a yeast Drbg1 strain expressing
Tma46–TAP. Coprecipitation of the two proteins was
Figure 5. Analysis of Rbg1 domains. (A) Complementation assay for Rbg1 function. The ability of plasmid-encoded Rbg1 mutants to complement
the growth phenotype of a triple Drbg1Drbg2Dslh1 strain was assayed by spotting serial dilution on selective plates and incubating at 30C or 37C
for 4 days. The structure of the various mutants is shown schematically on the left. WT strain indicates the original wild-type parental strain without
mutation. (B) Mutant protein accumulation. The level of accumulation of the mutant proteins in cells shown on panel A grown at 30C was assessed
by detecting the HA tag by western blotting. Uniform loading is supported by analysis of the levels of the endogenous Stm1 protein. (C) Interaction
between recombinant Tma46 and Rbg1 mutants. Plasmids harboring operons encoding His6-tagged Rbg1 [wild-type, point mutant (GFPSVGKN) or
mutant deleted for speciﬁc domains] together with Tma46 (either amino-acids 154–345 or 205–345) were used to express protein in E. coli.
Recombinant proteins puriﬁed on Ni–NTA agarose were detected by Coomassie staining. Organization of the different operons is shown on the
left. (D) Effect of C-terminal Tma46 truncation on binding to Rbg1 in yeast. Extracts prepared from Drbg1 strains carrying TAP-tagged Tma46 and
various HA-Rbg1 mutants grown at 30C were used for immunoprecipitation on IgG beads. As control for the speciﬁcity of the coprecipitation a
wild-type strain expressing wild-type Rbg1 tagged with HA was used. Proteins present in extracts (Input) and (co)precipitated factors (Eluate) were
analyzed by western blotting.
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assayed as described above (Figure 3). The results of this
experiment demonstrated that deletion of the HTH or
S5D2L had no impact on (HTH), or only reduced
slightly (S5D2L), the capacity of Rbg1 to bind Tma46
while no interaction was detected after removal of the
TGS domain (Figure 5D).
Altogether, consistent with the structure of the complex,
these results demonstrate that the HTH and S5D2L
domains do not contribute to Tma46 binding. These
data reveal, however, a critical role for the TGS domain
in the association of Tma46 with Rbg1.
We also assayed the GTPase activity of deletion
mutants of Rbg1 lacking the S5D2L, or TGS, domain
coexpressed with the C-terminal region of Tma46
(Tma46205–345). All mutants displayed a signiﬁcant GTP
hydrolytic activity albeit with reduced rate compared to
the wild-type protein (Table 2). This result indicates that
these two peripheral domains of Rbg1 are not essential for
GTPase activity although they may modulate catalysis.
Tma46 recruits Rbg1 in polysomes
Like their human homologs, Rbg1 and Tma46 have been
shown to associate with polysomes (15,17,19). Thus, we
next assessed the ability of Rbg1 deletion mutants to as-
sociate with polysomes. Extracts prepared from strains
expressing wild-type TAP tagged Tma46 and the various
mutant forms of Rbg1 tagged with an HA epitope were
layered on sucrose gradients. After centrifugation, frac-
tions of the gradients were collected while monitoring
RNA absorbance (Figure 6). Presence of Tma46 and
wild-type or mutant forms of Rbg1 in the various frac-
tions was monitored by western blotting.
As reported earlier (15), wild-type Rbg1 and Tma46
cosediment in polysomes (Figure 6A). A similar distribu-
tion was observed when the HTH or S5D2L domains were
deleted (Figure 6C and D), albeit increased free Rbg1
(consistent with a slightly reduced interaction with
Tma46, see above) was detected at the top of the
gradient in the latter case. Interestingly, removal of the
TGS domain from Rbg1 resulted in complete segregation
of the two proteins with Tma46 being localized in poly-
somes while Rbg1 remained at the top of the gradient
(Figure 6B). Taken together with the observation that
the TGS domain is sufﬁcient and necessary to mediate
interaction between Rbg1 and Tma46 (Figure 5), this ob-
servation is consistent with Tma46 mediating the recruit-
ment of Rbg1 in polysomes.
DISCUSSION
DRG proteins are extremely well-conserved factors
present in eukaryotes and archaea that belong to the
Obg/Drg GTPase subfamily (1). Characterized members
of the latter group have all been implicated in ribosome
genesis or function. Intriguingly, the two highly related
DRG GTPases found in eukaryotes associate with
rather distantly related DFRP cofactors, but still
mediate partly overlapping functions.
To gain insights into the mode-of-action of these
puzzling proteins, we determined the crystal structure of
one of the yeast DRG, namely Rbg1, in complex with a
fragment of its partner Tma46, and analyzed the func-
tional roles of newly uncovered structural elements.
Our results provide unexpected insights into the
Figure 6. Polysome association of Rbg1 mutants. Polysomes extracts
were prepared from cells expressing TAP-tagged Tma46 and HA-
tagged Rbg1 (wild-type or domain deletion mutants). Polysomes were
resolved by density sedimentation in 10–50% sucrose gradient. The UV
absorbance trace (254 nm) obtained by continuous monitoring during
fractionation is shown with the position of the 40S, 60S, 80S and poly-
somes peaks indicated. Fractions were analyzed by western blotting to
detect the TAP and HA tags. (A) Distribution of Tma46-TAP and
wild-type HA-Rbg1. (B) Distribution of Tma46-TAP and HA-Rbg1
TGS. (C) Distribution of Tma46-TAP and HA-Rbg1 S5D2L.
(D) Distribution of Tma46-TAP and HA-Rbg1 HTH. Previously
reported control analyses demonstrate that Rbg1 association with
polysome is speciﬁc (15).
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organization of DRG GTPases and into their mode of
interaction with DFRP partners, including the impact of
the latter on GTPase activity. Moreover, our data demon-
strate a key role of Tma46 in mediating Rbg1 recruitment
to polysomes. Sequence analyses suggest that a distantly
related mechanism is exploited by the second eukaryotic
DRG/DFRP pair (see below).
Sequence alignments had revealed the presence of
GTPase and TGS domains in DRG proteins, including
Rbg1. Moreover, the presence of an insertion implanted
between conserved GTPase signature elements had been
noticed (19). Our structure demonstrates that this inser-
tion adopts a speciﬁc fold that protuberates on the surface
of the Rbg1 GTPase module. This inserted domain,
S5D2L, is related to domain 2 of the bacterial S5
protein. This ribosomal protein paves the entrance of
the mRNA channel in the E. coli ribosome and is, inter-
estingly, the target of mutations affecting translational
ﬁdelity (51,52). The presence of a related domain in a
GTPase linked to ribosomal activity may thus be of func-
tional signiﬁcance. The structure of Rbg1 reveals in
addition the presence of a HTH at the extreme
N-terminus of the protein, whose presence had not been
foreseen by sequence analyses. The HTH domain packs
against the S5D2L while the TGS domain is distantly
located in space and thus do not contact these two units.
Overall, the Rbg1 protein, and related DRG factors,
appear to be a multidomain GTPase with the GTPase
core forming a platform on which are grafted three
domains forming two independent protuberances (HTH
and S5D2L on one side, and TGS on the other side).
Mutational analysis indicates that the GTPase activity is
absolutely required for Rbg1 function (15). Deletion of the
HTH or TGS domain also abrogates Rbg1 activity, while,
interestingly, removal of the S5D2L results in a condition-
ally active protein that is unable to function at high tem-
perature. Thus, all domains of Rbg1 are required for its
full activity. The S5D2L domain is not absolutely essential
for function and may either stimulate protein activity
under extreme conditions or be substituted by other
factors in less demanding situations.
In the crystal structure, the C-terminal fragment of
Tma46 adopts an extended conformation (Figure 1A)
made essentially of successive a-helices interconnected by
loops that meanders on the surface of the GTPase and
TGS domains of Rbg1. Interestingly, part of Tma46
embraces an area of Rbg1 that is close to the GTP-
binding site. Consistently, we observe that the presence
of Tma46 affect GTP binding and hydrolysis by Rbg1.
Tma46 may affect Rbg1 activity by strengthening
contacts between the G and TGS domain and/or may
modulate the GTPase activity through more subtle inter-
actions. Deletion analyses indicate that the surface of
interaction of Tma46 with Rbg1 can be reduced without
abrogating binding or abolishing function, as long as a
minimum is kept. Unexpectedly, all structural elements
of this region of Tma46 are individually not essential,
even if they contribute to binding and function. The
region of Tma46 interacting with Rbg1 shows only
limited conservation and is larger than the segment previ-
ously identiﬁed as the dfrp domain based on protein
alignment. This part of Tma46 is unlikely to adopt a
globular fold on its own, and thus probably corresponds
to an intrinsically unstructured polypeptide. Accordingly,
the Gir2 protein, that contains an equivalent region, has
been shown to be intrinsically unstructured (47). Our
results demonstrate that the C-terminal part of Tma46
contains structural elements superﬂuous for interaction
with Rbg1 and function. Taken together with the lack of
globular structure of this region and its extended conform-
ation, it is tempting to propose that Tma46 evolved by the
successive additions and extensions that increased its
ability to interact with the Rbg1 surface. Such an evolu-
tionary model is easy to imagine and fully consistent with
the lack of obvious Tma46 or Gir2 homologs in archaea
despite the presence of DRG homologs. Moreover, this
framework also provide for an explanation for the poor
sequence conservation of the Gir2 and Tma46 regions
mediating interaction with Rbg2 and Rbg1 in yeast, and
in the homologous proteins from other species, despite the
extraordinary conservation of DRG factors. Indeed, any
substitution arising in Dfrp protein still allowing efﬁcient
interaction with DRG factors will be accommodated, even
if this results in a slightly altered relative structural
arrangement. Overall, these constraints will result in an
asymmetric rate of evolution of the two partners, with
DRG factors changing slowly over time and DFRP
proteins exploring rapidly an extensive sequence space.
The availability of the Rbg1ﬂ–Tma46205–345 structure
might have provided explanation on why Rbg1 interacts
with Tma46 in vivo while Rbg2 interacts with Gir2 despite
the strong similarity between the two yeast DRG factors
(15,17). However, mutagenesis of candidate residues failed
to identify key amino acid interaction networks essential
to establish this speciﬁcity (data not shown). This suggests
that speciﬁcity is based on a large set of interactions rather
than a few key amino acids. It is noteworthy also that the
speciﬁc interaction of one DRG factor with a DFRP
partner is not absolute, as cross-interaction can be
detected in artiﬁcial conditions (19).
Contrasting with our observation that deletion of the
Tma46 ß strand and helices a3 and a4 only reduces
Rbg1–Tma46 interaction in vivo resulting in temperature
sensitive function, deletion of the Rbg1 TGS domain ab-
rogates the Rbg1–Tma46 interaction, both in vivo and in
assays based on recombinant proteins. This observation is
surprising because the region of Tma46 that interacts with
the Rbg1 TGS domain is composed of helices a3 and a4.
The latter result may indicate that the TGS domain con-
tributes to Tma46 binding both by providing an extensive
surface of contact for Tma46 and by maintaining the
GTPase domain in a conformation favorable for inter-
action. Binding assays using recombinant factors
conﬁrm that Tma46 interacts efﬁciently with the isolated
TGS while it binds inefﬁciently, at best, with a truncated
form of Rbg1 lacking the TGS domain. These data
support the idea that the stability of the Rbg1–Tma46
interaction resides for a major fraction in the area
involving the TGS domain and/or that the TGS domain
constitutes a primary nucleating center for the formation
of this heterodimer. This demonstrate that the Rbg1 TGS
domain has a critical role in mediating protein interaction
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and it will be of interest to test whether this property
extends to TGS domains present in other proteins.
Interestingly, deletion of the TGS domain in vivo
resulted in the fractionation of Tma46 and the mutant
Rbg1 in distinct regions in polysome gradients: while
Tma46 remained associated with polysomes, Rbg1 was
released and found as a free factor in the lighter fractions
of the gradient. This is a speciﬁc effect of the TGS
deletion, as similar distributions were not observed with
removal of the S5D2L or HTH domains of Rbg1. This
suggests that Tma46 associates with polysomes, possibly
through an interaction of its two Zn ﬁngers with mRNAs
and/or ribosomal RNAs, thereby recruiting Rbg1 in these
assemblies. These observations strengthen the role of
Rbg1 in translation and suggest that its GTPase would
be able to mediate a yet-to-be-deﬁned action on ribosomes
after its recruitment. Interestingly, a variant of this model
may apply to Rbg2 as well. Indeed, in speciﬁc conditions,
an interaction of the N-terminal RWD domain of Gir2
with ribosome bound Gcn1 may provide a means to
recruit Rbg2 to translating ribosome in a manner similar
to the recruitment of Gcn2 (16). Further structural and
biochemical work will be required to test the biological
relevance of this hypothesis.
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